{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T06:05:12Z","timestamp":1790921112502,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Talanta"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.talanta.2022.124127","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T13:48:54Z","timestamp":1669211334000},"page":"124127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Further quantitative in silico analysis of SARS-CoV-2 S-RBD Omicron BA.4, BA.5, BA.2.75, BQ.1, and BQ.1.1 transmissibility"],"prefix":"10.1016","volume":"254","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5297-8807","authenticated-orcid":false,"given":"Toshihiko","family":"Hanai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.talanta.2022.124127_bib1","first-page":"383","article-title":"Cocid-19, a pandemic or not?","volume":"20","year":"2020","journal-title":"www.thelancet.com\/infection"},{"key":"10.1016\/j.talanta.2022.124127_bib2","first-page":"874","volume":"396","author":"Horton","year":"2020","journal-title":"Offline: Covid-19 is not a pandemic"},{"key":"10.1016\/j.talanta.2022.124127_bib3","series-title":"Is the Covid-19 Pandemic Over,or Not?","author":"Shmerling","year":"2022"},{"key":"10.1016\/j.talanta.2022.124127_bib4","first-page":"1","article-title":"An optimistic outlook","author":"Topol","year":"2022","journal-title":"Ground Truths"},{"key":"10.1016\/j.talanta.2022.124127_bib5","year":"2022","journal-title":"SARS-CoV-2 variants of dashboard 10 Nov"},{"key":"10.1016\/j.talanta.2022.124127_bib6","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/d41586-021-02039-y","article-title":"How SARS-CoV-2 infects cells \u2013 and why Delta is so dangerous","volume":"595","author":"Scudellari","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.talanta.2022.124127_bib7","article-title":"Prior omicron infection protects against BA.4 and BA.5 variants","volume":"21","author":"Prillaman","year":"2022","journal-title":"Nature News"},{"key":"10.1016\/j.talanta.2022.124127_bib8","unstructured":"E.Topol, The BA.5 story, the takeover by this omicron sub-variant is not pretty, Ground Truths, November 8, 2022."},{"key":"10.1016\/j.talanta.2022.124127_bib9","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.cell.2022.06.005","article-title":"Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum","volume":"185","author":"Tuekprakhon","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.talanta.2022.124127_bib10","article-title":"Evasion of neutralizing antibodies by omicron sublineage BA.2.75","author":"Sheward","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.talanta.2022.124127_bib11","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/s41467-022-28446-x","article-title":"Synthetic virions reveal fatty acid-coupled adaptive immunogenicity of SARS-CoV-2 spike glycoprotein","volume":"13","author":"Staufer","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.talanta.2022.124127_bib12","unstructured":"Y. Hu, E.M. Lewandowski, H. Tan, X. Zhang, R.T. Morgan, X. Zhang, L.M.C. Jacobs, S.G. Bitler, M.V. Gongora, J. Choy, X. Deng, Y. Chen, J. Wang, bioRxiv preprint doi:\/\/doi.org\/10.1101\/2022.06.28.497978."},{"key":"10.1016\/j.talanta.2022.124127_bib13","article-title":"How COVUD-19 variants evade the immune response","author":"Doctrow","year":"2021","journal-title":"NIH Research Matter"},{"key":"10.1016\/j.talanta.2022.124127_bib14","doi-asserted-by":"crossref","unstructured":"P. Han, L. Li, S. Liu, Q. Wang, D. Zhang, Z. Xu, P. Hana, X. Li, Q. Peng, C. Su, B. Huang, D. Li, R. Zhang, M. Tian, L. Fu, Y. Gao, X. Zhao, K. Liu, J. Qi, G. Gao, P. Wang, Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2, Cell, 185 (202) 630-640. https:\/\/doi.org\/10.1016\/j.cell.2022.01.001.","DOI":"10.1016\/j.cell.2022.01.001"},{"key":"10.1016\/j.talanta.2022.124127_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2022.123206","article-title":"Quantitative in silico analysis of SARS-CoV-2 S-RBD omicron mutant transmissibility","volume":"240","author":"Hanai","year":"2022","journal-title":"Talanta"},{"key":"10.1016\/j.talanta.2022.124127_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/d41586-021-03829-0","article-title":"Omicron overpowers key CONID antibody treatments in early tests","author":"Kozlov","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.talanta.2022.124127_bib17","first-page":"942","article-title":"Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies","volume":"22","author":"Yamasoba","year":"2022","journal-title":"www.thelancet.com\/infection"},{"key":"10.1016\/j.talanta.2022.124127_bib18","author":"Hentzien","year":"2022","journal-title":"A monoclonal antibody stands out against omicron subvariants: a call to action for wider access to Bebtelovimab"},{"key":"10.1016\/j.talanta.2022.124127_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001237","article-title":"Cryo-electron microscopy structures of the N501Y SARA-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies","volume":"19","author":"Zhu","year":"2021","journal-title":"PLoS Biol."},{"key":"10.1016\/j.talanta.2022.124127_bib20","series-title":"T. Hanai, Quantitative Analysis of SARS-CoV-2 Variants Transmissibility, & S-RBD and ACE-2 Docking Inhibitors: T. Hanai, (Ed.) Quantitative in Silico Analytical Chemistry","first-page":"153","article-title":"SARS-CoV-2 transmissibility and the protein structures, HYAKUMANBEN TUSHIN,181, (2021) pp. 4-12, (in Japanese), & T. Hanai, Covid-19 transmissibility and food habitude, HYAKUMANBEN TUSHIN,182 (2021) 5\u20137, (in Japanese)","author":"Hanai","year":"2021"},{"key":"10.1016\/j.talanta.2022.124127_bib21","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jtcme.2021.12.002","article-title":"Exploring the therapeutic nature of limonoids and triterpenoids against SARS-CoV-2 by targeting nsp13, nsp14, and nsp15 through molecular docking and dynamics simulations","volume":"12","author":"Vardhan","year":"2022","journal-title":"J. Traditional and Complementary Medicine"},{"key":"10.1016\/j.talanta.2022.124127_bib22","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.jiph.2020.09.002","volume":"13","author":"Kumar","year":"2020","journal-title":"J. Inf. Pub. Health"},{"key":"10.1016\/j.talanta.2022.124127_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.cplett.2020.138068","article-title":"Identification of potential inhibitors of SARS-CoV-2 papain-like protease from tropane alkaloids from Schizanthus porridges: a molecular docking study","volume":"761","author":"Alfaro","year":"2020","journal-title":"Chem. Phys. Lett."},{"key":"10.1016\/j.talanta.2022.124127_bib23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jtcme.2021.10.003","article-title":"Targeting autophagy with natural products to prevent SARS-CoV-2 infection","volume":"12","author":"Vidoni","year":"2022","journal-title":"J. Traditional and Complementary Medicine"},{"key":"10.1016\/j.talanta.2022.124127_bib28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/d41586-022-00562-0","article-title":"Hundreds of Covid trials could provide a deluge of new drugs","volume":"603","author":"Ledford","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.talanta.2022.124127_bib25","article-title":"Investigating the potential antiviral activity drugs against SARS-CoV-2 by molecular docking simulation","volume":"318","author":"El-Hoshoudy","year":"2020","journal-title":"L. Mol. Liq."},{"key":"10.1016\/j.talanta.2022.124127_bib29","first-page":"1","article-title":"Turning the tide; natural products and natural-product-inspired chemicals as potential counters to SARS-Cov-2 infection","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.talanta.2022.124127_bib31","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.120.008662","article-title":"Effect of chloroquine, hydroxychloroquine, and Azithromycin on the corrected Q.T. interval in patients with SARS-CoV-2 infection","volume":"13","author":"Saleh","year":"2020","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"10.1016\/j.talanta.2022.124127_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07391102.2020.1758788","article-title":"Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment","author":"Boopathi","year":"2020","journal-title":"J. Biomol. Struct. Dynam."},{"key":"10.1016\/j.talanta.2022.124127_bib33","article-title":"Coronavirus drugs \u2013 a brief overview of past, present and future","volume":"2","author":"Basha","year":"2020","journal-title":"J. PeerScoentist"},{"key":"10.1016\/j.talanta.2022.124127_bib46","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41586-021-03431-4","volume":"593","author":"Yuan","year":"2021","journal-title":"Nature"},{"issue":"25","key":"10.1016\/j.talanta.2022.124127_bib34","doi-asserted-by":"crossref","first-page":"16584","DOI":"10.1021\/acsomega.1c01797","article-title":"Inhibition of the 3CL protease and SARS-CoV-2 replication by dalcetrapib","volume":"6","author":"Niesor","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.talanta.2022.124127_bib35","first-page":"53","article-title":"Computational view toward the inhibition of SARS-CoV-2 spike glycoprotein and the 3CL protease","volume":"8","author":"Qiao","year":"2020","journal-title":"Communication"},{"key":"10.1016\/j.talanta.2022.124127_bib36","series-title":"Dexamethasone Could Help in Severe Covid-19; the Old, Inexpensive Steroid Appears to Save Lives in a Large U.K. Trial","first-page":"3","author":"Jarvis","year":"2020"},{"key":"10.1016\/j.talanta.2022.124127_bib37","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/j.jiph.2020.10.015","article-title":"Dolutegravir, and Etravirine against main protease and RNA-dependent R.N.A. polymerase of SARS-CoV-2: a molecular docking and drug repurposing approach","volume":"13","author":"Indu","year":"2020","journal-title":"J. Inf. Pub. Health"},{"key":"10.1016\/j.talanta.2022.124127_bib30","first-page":"1","article-title":"Covid-19 Working group in Peru, Comprehensive virtual screening of 4.8K flavonoids reveals novel insights into allosteric inhibition of ASRS-CoV-2 Mpro","volume":"1115452","author":"Jimenez-Avalos","year":"2021","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.talanta.2022.124127_bib38","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.mjafi.2020.08.004","article-title":"Favipiravir: a new and emerging antiviral option in Covid-19","volume":"76","author":"Agrawal","year":"2020","journal-title":"Med. J. Armed Forces India"},{"issue":"5","key":"10.1016\/j.talanta.2022.124127_bib39","first-page":"262","article-title":"SARS-Cov-2 and influenza: a comparative overview and treatment implications","volume":"77","author":"Manzanares-Meza","year":"2020","journal-title":"Bol. Med. Hosp. Infant. Mex."},{"key":"10.1016\/j.talanta.2022.124127_bib40","article-title":"Structure genomics of SARS-CoV-2 and its omicron variant: drug design templates for Dovid-19","author":"Wu","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.talanta.2022.124127_bib48","first-page":"Sept","article-title":"Discovery of potential flavonoid inhibitor against COCID-19 3CL proteinase based on virtual screening strategy","volume":"29","author":"Xu","year":"2020","journal-title":"Front. Mil. Biosci."},{"key":"10.1016\/j.talanta.2022.124127_bib41","article-title":"A search for medications to treat COVID-9 via in silico molecular docking models of the SARS-CoV-2 spike glycoprotein and 3CL protease","volume":"35","author":"Hall","year":"2020","journal-title":"Travel med. Inf. Disease"},{"key":"10.1016\/j.talanta.2022.124127_bib24","first-page":"1","article-title":"Screening of phytochemicals as a potent inhibitor of 3-chymotrypsin and papain-like proteases of SARS-CoV-2: an in silico approach to combat Covid-19","author":"Swargiary","year":"2020","journal-title":"J. Biomol. Struct. Dynam."},{"key":"10.1016\/j.talanta.2022.124127_bib42","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jtcme.2021.12.002","article-title":"Exploring the therapeutic nature of limonoids and triterpenoids against SARS-CoV-2 by targeting nsp13, nsp14, and nsp15 through molecular docking and dynamic simulations","volume":"12","author":"Vardhan","year":"2022","journal-title":"J. Traditional and Complementary Medicine"},{"key":"10.1016\/j.talanta.2022.124127_bib43","first-page":"6","article-title":"What is oleandrin, the compound touted as a possible COVID-19 treatment? Scientists warn that the natural botanical product is unproven and could have lethal side effects","volume":"31","author":"Halford","year":"2020","journal-title":"C&EN, Aug."},{"key":"10.1016\/j.talanta.2022.124127_bib26","series-title":"Omicron: A Heavily Mutated SARS-CoV-2 Variant Exhibits Stronger Binding to ACE2 and Potently Escapes Approved COVID-19 Therapeutic Antibodies, bioTxiv","author":"Shah","year":"2021"},{"key":"10.1016\/j.talanta.2022.124127_bib47","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1126\/sciadv.abh1547","article-title":"A universal bacteriophage T4 nanoparticle platform to design multiplex SARS-CoV-2 vaccine candidates by CRISPR engineering","volume":"7","author":"Zhu","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.talanta.2022.124127_bib49","first-page":"12","article-title":"Protection from previous natural infection compared with mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar: a retrospective cohort study","author":"Chemaitelly","year":"2022","journal-title":"Lancet Microbe"}],"container-title":["Talanta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914022009237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914022009237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T13:04:19Z","timestamp":1758546259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039914022009237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":47,"alternative-id":["S0039914022009237"],"URL":"https:\/\/doi.org\/10.1016\/j.talanta.2022.124127","relation":{},"ISSN":["0039-9140"],"issn-type":[{"value":"0039-9140","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Further quantitative in silico analysis of SARS-CoV-2 S-RBD Omicron BA.4, BA.5, BA.2.75, BQ.1, and BQ.1.1 transmissibility","name":"articletitle","label":"Article Title"},{"value":"Talanta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.talanta.2022.124127","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"124127"}}